Nuvation Bio Inc.
NYSENuvation Bio heads into the late-May session with a sharp tension running through the data: short sellers are holding near a 30-day high in positioning, while the stock has just delivered its best weekly gain in months. The short interest picture is the dominant angle this week. Bears control roughly 21.2% of the free float — a figure that has held stubbornly in the 21–22% band…
Snapshot as of 22 Jun 2026
Nuvation Bio heads into the late-May session with a sharp tension running through the data: short sellers are holding near a 30-day high in positioning, while the stock has just delivered its best weekly gain in…
Nuvation Bio heads into its May 21 investor event with an intriguing split — one of the most heavily shorted names in pharma is quietly unwinding its short position even as a freshly announced manufacturing deal…
Nuvation Bio heads into its May 8 earnings report with short sellers making a clear statement — and options traders ignoring them entirely. Short interest has become the dominant feature of the positioning picture. At…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NUVB — free to start on ORTEX.
Sign up for free →Open NUVB on ORTEX